Skip to Content

Why does blood pressure stay high after stress? A chloride clue in amygdala cells

The Journal of clinical investigation · 2026-03-16

Table of contents

No titles in the blog post

The Journal of clinical investigation · Research frontiers

Why does blood pressure stay high after stress? A chloride clue in amygdala cells

In susceptible male rats, chronic stress increases CRF-labeled cell activity; NKCC1-associated chloride changes weaken GABA inhibition and accompany increased sympathetic output.

AI scientific concept illustration inspired by the research theme

Stress can raise heart rate and blood pressure. Why do some animals remain hypertensive after it ends? A Journal of Clinical Investigation study compares normotensive rats with borderline-hypertensive rats, following CRF-expressing cells in central amygdala, or CeA. Sustained stress increases their activity and changes the direction of their response to GABA. Chloride distribution and its transporter NKCC1 provide a mechanistic clue.

KEY FINDING

Stressed susceptible rats show depolarized GABA reversal potential and increased NKCC1 in CeA CRF cells. NKCC1 inhibition restores slice GABA inhibition, while central administration reduces sympathetic activity and blood pressure.

Contents · 7 sections

The same stress produces different recovery

Male borderline-hypertensive rats, or BHRs, are compared with normotensive WKY rats. BHRs are offspring of hypertensive and WKY strains, with higher baseline pressure and susceptibility. Both groups show increased mean arterial pressure during twenty-one days of stress, but WKY recovers rapidly while BHR elevation persists for at least twenty-one days afterward.

Heart rate and serum corticosterone increase in BHRs without significant corresponding WKY changes. CRF colabeling with the sustained-activity marker ΔFosB increases in CeA, prompting a question about this population’s role in persistent cardiovascular changes.

Original figure 1Blood-pressure trajectories and amygdala activity markers
Blood-pressure trajectories and amygdala activity markers
Original Figure 1: Blood pressure and heart rate before, during and after stress, with CeA CRF/ΔFosB staining. BHR pressure remains elevated and activity-associated CRF colabeling increases.
Source: Ma H et al. · The Journal of clinical investigation · CC BY
Original figure and English caption ↗

The cells fire more with comparable input

In stressed BHR slices, CRF-expressing cells are more depolarized and fire more spontaneously and under comparable current inputs. Stressed WKY cells lack the same significant changes. Both sustained pressure and increased excitability stand out in the susceptible background.

In anesthetized BHRs, 20- or 40-Hz activation raises mean arterial pressure, heart rate and renal sympathetic activity. Chemogenetic inhibition during stress also attenuates hypertension development. The population functionally contributes to sympathetic and circulatory output.

Original figure 3Sympathetic and circulatory responses to CRF-cell activation
Sympathetic and circulatory responses to CRF-cell activation
Original Figure 3: Optical activation validation and pressure, heart-rate and renal-sympathetic recordings in anesthetized BHRs. Stimulation at 20 and 40 Hz increases the measured outputs.
Source: Ma H et al. · The Journal of clinical investigation · CC BY
Original figure and English caption ↗

GABA remains, but its effect changes direction

GABA commonly inhibits neurons, but its effect depends on ionic conditions when receptors open. CeA GABA and GABAA-receptor levels do not significantly differ across groups. Cellular responses do: GABA hyperpolarizes CRF cells in unstressed BHRs but depolarizes them after stress.

GABA reversal potential shifts approximately 21.5 mV toward depolarization in stressed BHRs, with increased intracellular chloride estimated from that potential; WKY shows no equivalent change. The reversal potential marks where GABA-associated current changes direction, revealing an altered ionic environment for the same receptor signal.

Original figure 4GABA responses and chloride-related potential changes
GABA responses and chloride-related potential changes
Original Figure 4: GABA-evoked voltage responses, reversal-potential recordings and derived intracellular chloride. Stressed BHR cells show depolarizing changes.
Source: Ma H et al. · The Journal of clinical investigation · CC BY
Original figure and English caption ↗

The change centers on NKCC1

Chloride distribution depends on transport systems including NKCC1 and KCC2. Stressed BHR CeA shows increased membrane NKCC1 without significant KCC2 change; frontal cortex and rostral ventrolateral medulla lack equivalent changes in either protein, indicating regional and molecular selectivity.

CRF/NKCC1 colabeling increases in CeA, connecting transporter changes with the hyperexcitable population showing altered GABA responses. The next question is whether reducing NKCC1 activity can restore both ionic conditions and cellular activity.

Original figure 5Regional and cellular distribution of NKCC1 changes
Regional and cellular distribution of NKCC1 changes
Original Figure 5: NKCC1/KCC2 comparisons in CeA, frontal cortex and medulla, with CeA CRF/NKCC1 labeling. The prominent change is increased CeA NKCC1 in stressed BHRs.
Source: Ma H et al. · The Journal of clinical investigation · CC BY
Original figure and English caption ↗

NKCC1 blockade restores hyperpolarizing GABA responses

Bumetanide inhibition of NKCC1 restores GABA reversal potential and derived chloride in stressed BHR slices, reinstates hyperpolarizing responses and reduces spontaneous firing. Unstressed BHRs show no equivalent significant changes.

Adding the GABAA antagonist gabazine negates the firing reduction produced by bumetanide. Cellular inhibition after chloride-related restoration depends on GABAA signaling, linking transporter activity, reversal potential and firing functionally.

Original figure 6Cellular responses after NKCC1 inhibition
Cellular responses after NKCC1 inhibition
Original Figure 6: Bumetanide effects on GABA-associated currents, reversal potential, derived chloride and spontaneous firing. GABA inhibition is restored in stressed BHRs, and gabazine negates the firing reduction.
Source: Ma H et al. · The Journal of clinical investigation · CC BY
Original figure and English caption ↗

Central chloride regulation connects with sympathetic output

Intracerebroventricular bumetanide lowers pressure, heart rate and renal sympathetic activity in stressed BHRs, unlike vehicle. Subsequent CeA GABAA activation reduces outputs in both groups, with stronger pressure and sympathetic decreases after bumetanide pretreatment.

Bumetanide lacks equivalent circulatory effects in unstressed BHRs, and stressed WKY lacks the corresponding drug effects. Central NKCC1 inhibition has broader access than local CeA receptor activation; together they show dependence on susceptibility and stress state.

Original figure 7Pressure and sympathetic responses to central administration
Pressure and sympathetic responses to central administration
Original Figure 7: Pressure, heart-rate and renal-sympathetic recordings after ventricular bumetanide and local CeA muscimol. Pretreatment strengthens pressure and sympathetic reductions after local GABAA activation.
Source: Ma H et al. · The Journal of clinical investigation · CC BY
Original figure and English caption ↗

Stress changes the conditions for receiving inhibition

This male-rat study links sustained stress and cardiovascular changes to a cellular mechanism: inhibition depends on the receiving cell’s chloride conditions. In susceptible animals, NKCC1-associated changes weaken GABA inhibition of CRF cells alongside increased excitability and sympathetic output. Persistent hypertension involves how cells receive signals as well as signal strength.

Publication details

Ma H, Zhang Y, Guo X, Zhao Q, Yang P, Liu Y, Guan Y, Wei Y, Ma H.
Chloride homeostasis dysfunction drives hyperactivation of corticotropin-releasing factor-expressing neurons in the amygdala in stress-induced hypertension
The Journal of clinical investigation · 2026-03-16
DOI: 10.1172/jci195536